EUROPEAN LEFT ATRIAL APPENDAGE CLOSURE CLUB
Dedicated to improving the safety and efficacy of LAAC and ultimately to improve patient outcomes.
Join us in our commitment to promoting best practices, fostering collaboration, and ultimately improving patient outcomes.
Together, we can shape the future of left atrial appendage closure.
Welcome to the European Left Atrial Appendage Closure Club (ELAACC), a dynamic community of experts committed to advancing the field of left atrial appendage closure (LAAC) and ensuring optimal patient outcomes.
The club is driven by core values of professionalism, integrity, and ambition.
Why ELAACC?
Rising Importance of LAAC: With the increasing use of LAAC devices as a crucial alternative to long-term oral anticoagulation therapy, the need for a standardized approach and best practices has never been more critical. ELAACC is here to fill that gap.
Technical Challenges: LAAC remains a complex procedure demanding expertise in various areas, from imaging to device selection. Collaboration among specialists in interventional cardiology, electrophysiology, and imaging is key to optimizing every aspect of the procedure.
Evolving Technology: The field of LAAC is rapidly evolving with new devices and technologies. ELAACC serves as a hub for collaboration with companies, scientific societies, and major cardiology meetings to drive trials, suggest device innovations, and promote good clinical practices.
Practice Standardization: Addressing the current variability in LAAC practices across centers and countries, ELAACC is dedicated to promoting standardization in device selection, imaging techniques, and antithrombotic management.
Future Initiatives:
Annual Meeting: ELAACC is organizing an annual meeting, bringing together experts for interactive discussions and debates. This platform aims to develop consensus documents on patient selections, procedural techniques, and follow-up care for LAAC.
Registry Establishment: ELAACC is establishing a registry of LAAC procedures in Europe, extending its reach to other countries. This dedicated database will monitor outcomes and identify areas for improvement.
Multicenter Studies: ELAACC promotes multicenter studies, including randomized trials, to investigate the long-term safety and efficacy of LAAC, filling gaps in evidence and advancing the field.
Collaboration for Guidelines: ELAACC collaborates with other professional organizations to develop joint guidelines and consensus documents, ensuring a unified and evidence-based approach to LAAC.
In summary, the ELAACC is not just a club, it's a driving force for positive change in LAAC.
Meet the Committee
-
Dr Adel Aminian
CHU Charleroi, Belgium
-
Dr Sergio Berti
Fondazione CNR Regione Toscana, Massa, Italy.
-
Dr Ignacio Cruz-González
Hospital Universitario de Salamanca, IBSAL, CIBER-CV, Salamanca, Spain.
-
Dr Ole De Backer
Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
-
Dr Xavier Freixa
Institut Clinic Cardiovascular, Hospital Clínic, Barcelona, Spain.
-
Dr Philippe Garot
Institut Cardiovasculaire Paris Sud (ICPS) Hôpital J. Cartier, Massy, France
-
Dr Jens Erik Nielsen-Kudsk
Aarhus University Hospital, Aarhus, Denmark.
-
Dr Lorenz Räber
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
-
Dr Nina Wunderlich
Asklepios Klinik Langen, Frankfurt, Germany
ELAACC 2025
This year’s meeting is gratefully sponsored by the following companies specialising in the field of LAAO & LAAC.
Please contact us for more information on how to become a partner of the ELAACC 2025 meeting.